Academic and Community Cancer Research United (ACCRU) RU011301I: Adjuvant ado-trastuzumab emtansine (T-DM1) for older patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer Meeting Abstract


Authors: Freedman, R. A.; Polley, M. Y.; Dueck, A. C.; Hurria, A.; Muss, H. B.; Ruddy, K. J.; Hubbard, J. M.; Liu, H.; Rogak, L. J.; Basch, E. M.; Dakhil, S. R.; Huff, J. D.; Bajaj, M.; Wilkinson, M.; Al Baghadadi, T.; Benjamin, S.; Mowat, R. B.; Hudis, C. A.; Rugo, H. S.; Winer, E. P.
Abstract Title: Academic and Community Cancer Research United (ACCRU) RU011301I: Adjuvant ado-trastuzumab emtansine (T-DM1) for older patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer
Meeting Title: 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 15 Suppl.
Meeting Dates: 2016 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-05-20
Start Page: 41s
Language: English
ACCESSION: WOS:000404665401028
DOI: 10.1200/JCO.2016.34.15_suppl.TPS629
PROVIDER: wos
Notes: Meeting Abstract: TPS629 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Clifford Hudis
    905 Hudis
  2. Ethan Martin Basch
    180 Basch
  3. Lauren Jayne Rogak
    76 Rogak